ARC TALKS Webinar: Progress and Promise (Amyloidosis Treatment and Research 2026 in Review)

The amyloidosis landscape is ever changing. Join us to hear the latest advances from 2026 in transthyretin (ATTR) and light chain (AL) amyloidosis, and what’s on the horizon for 2027. A question-and-answer period will follow the presentation.